BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 17559499)

  • 1. An orthotopic floor-of-mouth model for locoregional growth and spread of human squamous cell carcinoma.
    Henson B; Li F; Coatney DD; Carey TE; Mitra RS; Kirkwood KL; D'Silva NJ
    J Oral Pathol Med; 2007 Jul; 36(6):363-70. PubMed ID: 17559499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel arthritis-associated osteoclast precursor macrophage regulated by FoxM1.
    Hasegawa T; Kikuta J; Sudo T; Matsuura Y; Matsui T; Simmons S; Ebina K; Hirao M; Okuzaki D; Yoshida Y; Hirao A; Kalinichenko VV; Yamaoka K; Takeuchi T; Ishii M
    Nat Immunol; 2019 Dec; 20(12):1631-1643. PubMed ID: 31740799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TAF10-containing TFIID and SAGA transcriptional complexes are dispensable for early somitogenesis in the mouse embryo.
    Bardot P; Vincent SD; Fournier M; Hubaud A; Joint M; Tora L; Pourquié O
    Development; 2017 Oct; 144(20):3808-3818. PubMed ID: 28893950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a xenograft model to explore the mechanism of bone destruction by human oral cancers and its application to analysis of role of RANKL.
    Tohyama R; Kayamori K; Sato K; Hamagaki M; Sakamoto K; Yasuda H; Yamaguchi A
    J Oral Pathol Med; 2016 May; 45(5):356-64. PubMed ID: 26859422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RANKL synthesized by both stromal cells and cancer cells plays a crucial role in osteoclastic bone resorption induced by oral cancer.
    Sato K; Lee JW; Sakamoto K; Iimura T; Kayamori K; Yasuda H; Shindoh M; Ito M; Omura K; Yamaguchi A
    Am J Pathol; 2013 May; 182(5):1890-9. PubMed ID: 23499553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RANKL/RANK system as a therapeutic target for bone invasion by oral squamous cell carcinoma (Review).
    Jimi E; Shin M; Furuta H; Tada Y; Kusukawa J
    Int J Oncol; 2013 Mar; 42(3):803-9. PubMed ID: 23354319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zoledronic acid reduces bone loss and tumor growth in an orthotopic xenograft model of osteolytic oral squamous cell carcinoma.
    Martin CK; Werbeck JL; Thudi NK; Lanigan LG; Wolfe TD; Toribio RE; Rosol TJ
    Cancer Res; 2010 Nov; 70(21):8607-16. PubMed ID: 20959474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of interleukin-6 and parathyroid hormone-related peptide in osteoclast formation associated with oral cancers: significance of interleukin-6 synthesized by stromal cells in response to cancer cells.
    Kayamori K; Sakamoto K; Nakashima T; Takayanagi H; Morita K; Omura K; Nguyen ST; Miki Y; Iimura T; Himeno A; Akashi T; Yamada-Okabe H; Ogata E; Yamaguchi A
    Am J Pathol; 2010 Feb; 176(2):968-80. PubMed ID: 20035059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of the fibrous stroma in bone invasion by human gingival squamous cell carcinomas.
    Ishikuro M; Sakamoto K; Kayamori K; Akashi T; Kanda H; Izumo T; Yamaguchi A
    Bone; 2008 Sep; 43(3):621-7. PubMed ID: 18585993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotrophin Pathway Receptors NGFR and TrkA Control Perineural Invasion, Metastasis, and Pain in Oral Cancer.
    Doan C; Aouizerat BE; Ye Y; Dang D; Asam K; Bhattacharya A; Howard T; Patel YK; Viet DT; Figueroa JD; Zhong JF; Thomas CM; Morlandt AB; Yu G; Callahan NF; Allen CT; Grandhi A; Herford AS; Walker PC; Nguyen K; Kidd SC; Lee SC; Inman JC; Slater JM; Viet CT
    Adv Biol (Weinh); 2022 Sep; 6(9):e2200190. PubMed ID: 35925599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases.
    Arosarena OA; Barr EW; Thorpe R; Yankey H; Tarr JT; Safadi FF
    J Cell Physiol; 2018 Jan; 233(1):409-421. PubMed ID: 28295306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoactivin Promotes Migration of Oral Squamous Cell Carcinomas.
    Arosarena OA; Dela Cadena RA; Denny MF; Bryant E; Barr EW; Thorpe R; Safadi FF
    J Cell Physiol; 2016 Aug; 231(8):1761-70. PubMed ID: 26636434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reviewing and reconsidering invasion assays in head and neck cancer.
    Inglehart RC; Scanlon CS; D'Silva NJ
    Oral Oncol; 2014 Dec; 50(12):1137-43. PubMed ID: 25448226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The G protein-coupled receptor GALR2 promotes angiogenesis in head and neck cancer.
    Banerjee R; Van Tubergen EA; Scanlon CS; Vander Broek R; Lints JP; Liu M; Russo N; Inglehart RC; Wang Y; Polverini PJ; Kirkwood KL; D'Silva NJ
    Mol Cancer Ther; 2014 May; 13(5):1323-33. PubMed ID: 24568968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioluminescent imaging of HPV-positive oral tumor growth and its response to image-guided radiotherapy.
    Zhong R; Pytynia M; Pelizzari C; Spiotto M
    Cancer Res; 2014 Apr; 74(7):2073-81. PubMed ID: 24525739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAM17-mediated CD44 cleavage promotes orasphere formation or stemness and tumorigenesis in HNSCC.
    Kamarajan P; Shin JM; Qian X; Matte B; Zhu JY; Kapila YL
    Cancer Med; 2013 Dec; 2(6):793-802. PubMed ID: 24403253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative genomics in combination with RNA interference identifies prognostic and functionally relevant gene targets for oral squamous cell carcinoma.
    Xu C; Wang P; Liu Y; Zhang Y; Fan W; Upton MP; Lohavanichbutr P; Houck JR; Doody DR; Futran ND; Zhao LP; Schwartz SM; Chen C; Méndez E
    PLoS Genet; 2013; 9(1):e1003169. PubMed ID: 23341773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rab25 regulates invasion and metastasis in head and neck cancer.
    Amornphimoltham P; Rechache K; Thompson J; Masedunskas A; Leelahavanichkul K; Patel V; Molinolo A; Gutkind JS; Weigert R
    Clin Cancer Res; 2013 Mar; 19(6):1375-88. PubMed ID: 23340300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral squamous carcinoma cells secrete RANKL directly supporting osteolytic bone loss.
    Zhang X; Junior CR; Liu M; Li F; D'Silva NJ; Kirkwood KL
    Oral Oncol; 2013 Feb; 49(2):119-28. PubMed ID: 22989723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor-interacting protein (RIP) and Sirtuin-3 (SIRT3) are on opposite sides of anoikis and tumorigenesis.
    Kamarajan P; Alhazzazi TY; Danciu T; D'silva NJ; Verdin E; Kapila YL
    Cancer; 2012 Dec; 118(23):5800-10. PubMed ID: 22674009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.